| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 10% | 0% | $1,676,216 | +$645,794 | 886,887 | +63% | Perceptive Advisors LLC | 30 Sep 2025 |
| ORBIMED ADVISORS LLC | 20% | $1,498,823 | 760,824 | ORBIMED ADVISORS LLC | 31 Dec 2024 | |||
| Squadron Capital Management LLC | 8.4% | +40% | $1,116,990 | +$322,243 | 591,000 | +41% | Squadron Capital Management LLC | 30 Sep 2025 |
| Ikarian Capital, LLC | 10% | 0% | $1,161,319 | +$384,637 | 589,502 | +50% | Ikarian Capital, LLC | 31 Mar 2025 |
| Chernett Jorey | 6.8% | $668,220 | 543,268 | Chernett Jorey | 14 Jan 2026 | |||
| Ayrton Capital LLC | 9.9% | $795,190 | 403,650 | Ayrton Capital LLC | 31 Dec 2024 | |||
| Adage Capital Management, L.P. | 4.7% | -26% | $623,700 | 330,000 | 0% | Adage Capital Management, L.P. | 30 Sep 2025 | |
| Alyeska Investment Group, L.P. | 9.9% | $595,436 | 302,252 | Alyeska Investment Group, L.P. | 31 Dec 2024 |
As of 30 Sep 2025, 18 institutional investors reported holding 1,304,595 shares of Traws Pharma, Inc. - Common (TRAW). This represents 16% of the company’s total 7,989,235 outstanding shares.
The largest institutional shareholders of Traws Pharma, Inc. - Common (TRAW) together control 16% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 7.6% | 605,531 | 0% | 0.03% | $1,120,232 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.1% | 330,000 | 0% | 0% | $610,500 |
| Vestal Point Capital, LP | 1.9% | 150,000 | +0.13% | 0.01% | $277,500 |
| VANGUARD GROUP INC | 1.1% | 87,259 | +562% | 0% | $161,429 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.54% | 43,440 | +22% | 0% | $80,366 |
| Ikarian Capital, LLC | 0.36% | 28,493 | 0% | 0.01% | $52,712 |
| TWO SIGMA INVESTMENTS, LP | 0.28% | 22,018 | +37% | 0% | $40,733 |
| HRT FINANCIAL LP | 0.16% | 12,573 | 0% | $23,000 | |
| XTX Topco Ltd | 0.13% | 10,708 | 0% | $19,810 | |
| BlackRock, Inc. | 0.12% | 9,956 | 0% | 0% | $18,419 |
| CITIGROUP INC | 0.04% | 3,528 | +5780% | 0% | $6,527 |
| MORGAN STANLEY | 0.01% | 719 | 0% | 0% | $1,330 |
| SBI Securities Co., Ltd. | 0% | 162 | 0% | 0% | $300 |
| BANK OF AMERICA CORP /DE/ | 0% | 102 | +8.5% | 0% | $189 |
| Vermillion & White Wealth Management Group, LLC | 0% | 96 | 0% | 0% | $178 |
| UBS Group AG | 0% | 6 | -100% | 0% | $11 |
| FMR LLC | 0% | 2 | 0% | 0% | $4 |
| ASSETMARK, INC | 0% | 2 | 0% | $4 | |
| Tower Research Capital LLC (TRC) | 0% | 0 | -100% | $0 | |
| TWO SIGMA SECURITIES, LLC | 0% | 0 | -100% | $0 | |
| Alyeska Investment Group, L.P. | 0% | 0 | -100% | $0 | |
| RAYMOND JAMES FINANCIAL INC | 0% | 0 | -100% | $0 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 1,304,595 | $2,413,244 | +$101,966 | $1.85 | 18 |
| 2025 Q2 | 1,263,487 | $1,869,962 | -$1,075,286 | $1.48 | 19 |
| 2025 Q1 | 1,732,309 | $3,984,315 | +$1,207,344 | $2.30 | 18 |
| 2024 Q4 | 1,141,975 | $10,140,752 | +$4,400,866 | $8.88 | 17 |
| 2024 Q3 | 646,356 | $3,800,574 | +$3,742,032 | $5.88 | 10 |